All funds

DNB Fund Women's Health D1 NOK (Acc)

Equity fund

No data to display ...

1 year

Globe

USA

Largest region

High

Risk

Annual costs

Morningstar

 

Partial 

Sustainability

Development

Last 5 years

Details

  • DNB Fund Women’s Health er et globalt, tematisk aksjefond som investerer i selskaper som utvikler produkter og tjenester rettet mot kvinners helsebehov gjennom hele livsløpet. Investeringsuniverset omfatter selskaper på tvers av sektorer, fra legemidler og medisinsk teknologi til diagnostikk og konsumentrettet helse
    Read more

Investment horizon

  • DNB Fund Women's Health D1 NOK (Acc) is a Equity fund. This mutual fund type is suitable for those who plan to save for at least 6 years.

Characteristics

  • Minimum amount
  • Sharpe 3 years
  • NAV/Price

    07 Oct 2026

  • Margin rate
  • Start date
    17 Aug 2026
  • ISIN
    LU3443186971

Risk

  • High (5 of 7)

Morningstar rating

  • The Morningstar Rating is an objective standard that tells us how well a fund has done compared to similar funds. If a fund performs better than other funds it is compared with, it receives a high rating. Correspondingly, a fund receives a low rating if it performs worse than similar funds.

Sustainability

Annual cost

  • Ongoing costs

    Includes management fees of 0,75 %

  • Platform fee
  • Kickback fee
  • Annual running costs

Other costs

  • Performance-based fee
  • Transaction costs

  • Costs for any currency exchanges are not included.

Allocation

  • No data

Portfolio

Shows the fund's largest investments.

  • argenx SE
    6.2%
  • Eli Lilly and Co
    5.2%
  • Roche Holding AG Ordinary Shares new
    5.0%
  • TG Therapeutics Inc
    4.5%
  • Daiichi Sankyo Co Ltd
    4.3%
  • Novartis AG Registered Shares
    4.3%
  • Corcept Therapeutics Inc
    4.2%
  • UCB SA
    4.1%
  • Celcuity Inc
    3.7%
  • Genmab AS
    3.3%